Cencora (COR) Gains 13.2% YTD: What's Driving the Stock?

The rally in the company's share price can be attributed to the robust growth in the company's U.S. Healthcare Solutions segment. The optimism led by a solid second-quarter fiscal 2024 performance and robust business potential are expected to contribute further. Cencora exited second-quarter fiscal 2024 with decent results. The company witnessed solid top-line and bottom-line performances in the reported quarter, which is likely to have aided in the price growth. In the fiscal second quarter, Cencora's U.S. ...